Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Analogs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Study completedNCT00331188
What this trial is testing

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Who this might be right for
Esophageal VaricesPortal HypertensionGastric Varices+1 more
Debiovision 70
Testing effectiveness (Phase 2)Study completedNCT01128192
What this trial is testing

Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers

Who this might be right for
Hyperglycemia
Robert R. Henry, MD 45
Large-scale testing (Phase 3)Study completedNCT01412424
What this trial is testing

Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

Who this might be right for
Acromegaly
Chiasma, Inc. 155
Large-scale testing (Phase 3)Study completedNCT02384122
What this trial is testing

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

Who this might be right for
AngiodysplasiaVascular MalformationsGastrointestinal Hemorrhage+1 more
Radboud University Medical Center 62
Large-scale testing (Phase 3)Study completedNCT01460706
What this trial is testing

Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

Who this might be right for
Glioma
Turku University Hospital 30
Early research (Phase 1)Study completedNCT00446082
What this trial is testing

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Who this might be right for
Carcinoid TumorAcromegaly
Novartis Pharmaceuticals 85
Early research (Phase 1)UnknownNCT04138342
What this trial is testing

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Who this might be right for
Breast CancerSkin CancerSkin Diseases
Al-Azhar University 30
Not applicableStudy completedNCT00703079
What this trial is testing

Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly

Who this might be right for
Acromegaly
Federico II University 100
Testing effectiveness (Phase 2)Study completedNCT02351128
What this trial is testing

Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues

Who this might be right for
Carcinoma, Merkel Cell
University Hospital, Grenoble 35
Early research (Phase 1)Study completedNCT06372652
What this trial is testing

TE-8214 Solution in Healthy Volunteers

Who this might be right for
Acromegaly
Immunwork, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01670110
What this trial is testing

Pasireotide LAR in Severe Polycystic Liver Disease

Who this might be right for
Somatostatin AnalogsPolycystic Liver DiseaseAutosomal Dominant Polycystic Kidney Disease+1 more
Mayo Clinic 48
Not applicableUnknownNCT00569738
What this trial is testing

Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor
Hadassah Medical Organization 20
Not applicableStudy completedNCT01723748
What this trial is testing

Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

Who this might be right for
AcromegalyMetabolic Diseases
University of Aarhus 18
Not applicableApproved For MarketingNCT02705313
What this trial is testing

EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx

Who this might be right for
Neuroendocrine Tumors
Advanced Accelerator Applications
Not applicableStudy completedNCT04696042
What this trial is testing

Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs

Who this might be right for
Neuroendocrine Tumors
Asan Medical Center 71
Post-approval studies (Phase 4)Study completedNCT00595140
What this trial is testing

Acute Application of Pegvisomant and Octreotide in Acromegaly

Who this might be right for
Acromegaly
Ludwig-Maximilians - University of Munich 10
Not applicableWithdrawnNCT01371045
What this trial is testing

Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs

Who this might be right for
Acromegaly
Cedars-Sinai Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT04837885
What this trial is testing

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases

Who this might be right for
Neuroendocrine TumorLiver MetastasesNeuroendocrine Gastroenteropancreatic Tumour
University Hospital, Bordeaux 23
Early research (Phase 1)UnknownNCT03478358
What this trial is testing

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 60